Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
THD S.p.A. is a global medical technology company specializing in the development of innovative surgical and diagnostic solutions for coloproctology. The company is best known for pioneering the THD® Doppler procedure, a minimally invasive surgical technique for hemorrhoids that utilizes ultrasound guidance to ligate terminal branches of the superior rectal artery, preserving anal anatomy and reducing recovery time. Beyond surgical tools, THD offers a comprehensive suite of diagnostic products, including the THD® Anopress for portable anorectal manometry and the THD® ProctoStation, a modular platform for integrated anorectal examinations. Headquartered in Italy, the company maintains a significant international presence through subsidiaries and a vast distribution network, focusing on improving patient outcomes through less invasive clinical pathways.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on THD.